Category: Varian Medical Systems
California's Varian Medical Systems authorizes a share buyback program of up to $6 million in common stock.
Palo Alto, Calif.-based Varian Medical (NYSE:VAR) announced today the authorization of a $6 million common stock buyback program, authorized by its board of directors.
Investors shave nearly 7% from Varian Medical's share price after the medical device company misses 4th-quarter earnings expectations and reports slowing sales.
Varian Medical (NYSE:VAR) finished fiscal 2013 ahead of Wall Street's estimates, but investors still shaved nearly 7% from its share price yesterday.
Varian Medical Systems wins 510(k) clearance from the FDA for its RapidPlan treatment planning software for radiation oncology.
Varian Medical (NYSE:VAR) said it won 510(k) clearance from the FDA for its RapidPlan treatment planning software.
The U.K.'s NHS Supply Chain orders 20 TrueBeam radiosurgery systems from Varian Medical Systems, doubling last year’s order.
The British NHS Supply Chain bought 20 of Varian Medical Systems' (NYSE:VAR) TrueBeam devices as part of a planned upgrade of radiotherapy and radiosurgery systems in the nation's hospitals.
Rival radiological device makers Elekta and Varian Medical settle a lawsuit accusing the Swedish company of poaching sales reps and trade secrets from Varian.
Varian battles significant Japanese headwinds during its 3rd quarter, with declines in its X-ray tube business off-setting progress in other divisions.
Varian Medical Systems (NYSE:VAR) got a little Wall Street love today, despite reporting significant Q3 headwinds that spurred an adjustment of the company's full-year guidance.
A new reimbursement proposal from the Center for Medicare & Medicaid Services would level payments for brain tumor radiosurgery performed with technology from either Swedish Elekta and California-based Varian.